Researchers uncover a potential new therapeutic target for a hard-to-treat form of leukemia

A new target for potential treatments for blast phase myeloproliferative neoplasm (BP-MPN), one of the most aggressive forms of leukemia, has been identified by a research team at the University of Oxford.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup